☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
Roche
Roche’s Reports the US FDA’s Approval of Itovebi as a Treatment for HR+ and HER2- breast cancer with a PIK3CA mutation
October 11, 2024
Roche’s Ventana CLDN18 (43-14A) RxDx Assay Receives CE Mark Approval to Diagnose G/GEJ Cancer Patients with CLDN18 Protein Express...
October 10, 2024
Roche Reports Topline Data from P-III (REGENCY) Trial of Gazyva/Gazyvaro (Obinutuzumab) for Treating Lupus Nephritis
September 26, 2024
Roche Reports Topline Data from P-III (CENTERSTONE) Study of Xofluza to Reduce the Transmission of Influenza Virus
September 19, 2024
Roche Reports the US FDA’s Approval of Ocrevus Zunovo for Treating Relapse and Progressive Multiple Sclerosis
September 16, 2024
Roche’s Tecentriq Hybreza Receives the US FDA’s Approval for Cancer Treatment
September 13, 2024
Load more...
Back to Home
Modal title
×
Modal body text goes here.